Update of penetrance estimates in Birt-Hogg-Dubé syndrome.
Saved in:
| Title: | Update of penetrance estimates in Birt-Hogg-Dubé syndrome. |
|---|---|
| Authors: | Bruinsma FJ; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia fiona.bruinsma@cancervic.org.au.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia., Dowty JG; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia., Win AK; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Carlton, Victoria, Australia., Goddard LC; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia., Agrawal P; Department of Radiology, University of Michigan Michigan Medicine, Ann Arbor, Michigan, USA., Attina' D; Department of Radiology, Azienda Ospedaliero-Universitaria di Bologna IRCCS, Bologna, Italy., Bissada N; Department of Urology, Baylor College of Medicine, Houston, Texas, USA., De Luise M; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Eisen DB; Department of Dermatology, University of California Davis, Davis, California, USA., Furuya M; Pathology Centre, Genetic Lab Co., Ltd, Sapporo, Japan.; BHD-Net Japan, Hokkaido, Japan., Gasparre G; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., Genuardi M; Department of Life Sciences and Public Health, Universita' Cattolica di Sacro Cuore, Roma, Italy.; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy., Gerdes AM; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Hansen TVO; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Kobenhavn, Denmark., Houweling AC; Department of Human Genetics, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Johannesma PC; Department of Pulmonary Disease, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Lencastre A; Servico de Dermatologia, Hospital de Santo Antonio dos Capuchos, Lisboa, Portugal., Lim D; Clinical Genetic Unit, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK., Lindor NM; Mayo Clinic, Phoenix, Arizona, USA., Luzzi V; Department of Experimental and Clinical Medicine, Interventional Pulmonology Unit, Careggi University Hospital, Florence, Italy., Lynch M; St Vincent's University Hospital, Dublin, Ireland., Maffé A; SS Genetica e Biologia Molecolare ASO.S, Cuneo, Italy., Menko FH; Family Cancer Clinic, Antoni van Leeuwenhoek Hospital, the Netherlands Cancer Institute, Amsterdam, Netherlands., Michels G; Department of Acute and Emergency Care, St Antonius Hospital Eschweiler, Eschweiler, Germany., Pulido JS; Mayo Clinic, Rochester, Minnesota, USA.; Department of Translational Ophthalmology, Wills Eye Hospital, Philadelphia, Pennsylvania, USA., Ryu JH; Mayo Clinic, Rochester, Minnesota, USA., Sattler EC; Department of Dermatology and Alleregy, LMU Munich, Munich, Germany., Steinlein OK; Department of Genetics, University Hospital, LMU Munich, Munich, Germany., Tomassetti S; Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy., Tucker K; Hereditary Cancer Centre, Prince of Wales Hospital, Sydney, New South Wales, Australia.; Division of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Turchetti D; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., van de Beek I; Department of Human Genetics, Amsterdam UCM, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., van Riel L; Department of Human Genetics, Amsterdam UCM, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., van Steensel M; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore., Zenone T; Department of Internal Medicine, Centre Hospitalier de Valence, Valence, France., Zompatori M; IRCCS Multimedica Group, San Giuseppe Hospital, Milan, Italy., Walsh J; Centre of Research Excellence in Pulmonary Fibrosis, The University of Sydney, Sydney, New South Wales, Australia., Bondavalli D; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, Victoria, Australia., Maher ER; Birmingham Women's and Children's NHS Foundation Trust, Clinical Genetics Unit, West Midlands Regional Genetics Services, Birmingham, UK.; Department of Medical Genetics, University of Cambridge, Cambridge, UK., Winship IM; Genetic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia. |
| Corporate Authors: | Genetic Susceptibility Working Group I-CONFIRM |
| Source: | Journal of medical genetics [J Med Genet] 2023 Apr; Vol. 60 (4), pp. 317-326. Date of Electronic Publication: 2023 Feb 27. |
| Publication Type: | Review; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
